Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Neurology

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study

BMC NeurologyBMC series – open, inclusive and trusted201717:171

https://doi.org/10.1186/s12883-017-0952-9

Received: 21 April 2017

Accepted: 24 August 2017

Published: 4 September 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
21 Apr 2017 Submitted Original manuscript
11 Jul 2017 Reviewed Reviewer Report - Adam Handel
2 Aug 2017 Author responded Author comments - Chiara Zecca
Resubmission - Version 2
2 Aug 2017 Submitted Manuscript version 2
23 Aug 2017 Author responded Author comments - Chiara Zecca
Resubmission - Version 3
23 Aug 2017 Submitted Manuscript version 3
Publishing
24 Aug 2017 Editorially accepted
4 Sep 2017 Article published 10.1186/s12883-017-0952-9

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Multiple Sclerosis Center, Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano
(2)
Merck (Schweiz) AG
(3)
Multiple Sclerosis Center, Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano

Advertisement